Abstract:Objective To study the changes in T cell subsets and IL-7 in HIV-1-infected patients after seven years of highly active antiretroviral therapy (HAART). Methods Seventy-five individuals were included in this study (25 with effective HAART, 18 with ineffective HAART, 17 untreated HIV+ patients, and 15 volunteers in the HIV negative control group). The counts of CD4 + , CD8 + , CD8/CD38 + , and CD8/HLADR + T cells as well as the IL-7 protein expression was measured at 5 time points during a period of seven years in patients starting HAART (baseline) and in the HIV negative control group. The expression of CD127 on CD3 + T cells was measured by flow cytometry at a single time point (after 7 years) in patients with HAART and was compared with untreated HIV+ patients and the HIV negative control group. Results At baseline CD4 + T cell counts of HIV-1-infected patients were lower than that in the control group (p < 0.01), whereas the CD8 + , CD8/HLADR + and CD8/CD38 + T cell counts were higher than those in the control group ( p < 0.01). After seven years of effective HAART, the CD4 + T cell counts had increased and the CD8 + T cell count had decreased, although not to the normal levels ( p < 0.05). Both the CD8/HLADR + and CD8/CD38 + T cell counts had gradually approached those of the control group ( p > 0.05). In the ineffective HAART group, the CD8/CD38 + T cell count had not decreased significantly, and CD8/HLADR + T cell count gradually decreased. Before treatment, IL-7 serum levels of patients were significantly higher than that in the control group ( p < 0.01). After seven years of effective HAART, IL-7 levels had gradually decreased, but were still higher than in the control group ( p < 0.01). The CD127 expression on CD3 + CD8 + T cells in effective HAART patients was higher than in untreated HIV+ patients ( p < 0.05), but was lower than that in the control group ( p < 0.05). CD127 expression on CD3 + CD4+ T cells was not significantly different among the control group, untreated HIV+ patients and effective HAART group. Conclusion After seven years of effective HAART, the quantity and capacity of T cell subsets and IL-7 in HIV-1-infected patients had been partially restored, and the abnormal immune activation has significantly diminished.

Equilibrium State of T Helper Type 17 Cells and Treg Cells with Human Immunodeficiency Virus Infection

Relation of the Equilibrium State of Th17 and Treg Cells with Tuberculosis

Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection.

The comparative study of T helper cell type 17/regulatory T cell balance in human immunodeficiency virus type 1-infected homosexual patients and healthy donors

P16-14. Loss of balance between CD4+ regulatory T cell and Th17 population in chronic HIV infection

Study of T Cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART

[Relationship of CD4+ CD25hi Regulatory T (treg) Cells to Disease Progression in HIV-infected Patients].

A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients

The Changes of Th17, Tr Cells and IL-17 in the Process of Antiviral Treatment of Hunan AIDS Patients

Regulatory T cells and T helper 17 cells in viral infection

Th17/Treg ratio in HIV-1infected intravenous drug users and association with disease progression and monocyte activation

Immune reconstitution in HIV-1 infected individuals with long-term highly active antiretroviral therapy

T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable.

Alterations of the frequency and functions of follicular regulatory T cells and related mechanisms in HIV infection

CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status

Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients

CD4CD25 regulatory T cells in HIV infection

Progress of HIV-specific CTL Responses among HIV-infected Individuals

Impact of HIV Infection on T Follicular Helper Cells

High Frequency of Regulatory T Cells among HIV Type 1-Infected Men Who Have Sex with Men Correlates with Disease Progression.

IL-10+ NK and TGF-β+ NK cells play negative regulatory roles in HIV infection